Open AccessSTAY ALERT ABOUT COAGULATION PARAMETERS - IMPLICATIONS OF THROMBOSIS TREATMENT IN COVID-19
Author(s) -
Piotr Sielatycki,
Edyta Zbroch,
Martyna Markowska,
Aleksandra Zalewska,
Aleksandra Bowtruczuk,
Jedrzej Warpecowski,
Malgorzata Gryciuk
Publication year - 2022
Publication title -
journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.249
H-Index - 172
eISSN - 1473-5598
pISSN - 0263-6352
DOI - 10.1097/01.hjh.0000837080.71059.a8
Subject(s) - medicine , rivaroxaban , fondaparinux , pulmonary embolism , apixaban , anticoagulant , thrombosis , low molecular weight heparin , heparin , hydroxychloroquine , intensive care medicine , surgery , covid-19 , warfarin , atrial fibrillation , venous thromboembolism , disease , infectious disease (medical specialty)